- 15 New England Executive Park
- Burlington, MA, United States
- Website
- About Coronado is a biopharmaceutical company focused on novel immunotherapy agents for cancer and inflammatory diseases. Coronado’s two principal pharmaceutical product candidates are initially targeted for clinical development for inflammatory bowel disease, multiple sclerosis and acute myeloid leukemia.
